Roivant Sciences (ROIV) Tax Rate (2020 - 2026)
Roivant Sciences' (ROIV) quarterly Tax Rate came in at 1.34% in Q2 2026, up 307.0% on a YoY basis from 0.33% in Q2 2025, and up 127.61% quarter-over-quarter from 4.87% in Q4 2025.
Powered by 
Analysis
Roivant Sciences (ROIV) Tax Rate (2020 - 2026) Analysis & Trends
Roivant Sciences (ROIV) has reported Tax Rate for 7 consecutive years, with 1.34% the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Tax Rate rose 307.0% year-over-year to 1.34%; the trailing twelve-month figure through Jun 2026 stood at 2.96% (down 261.0% YoY), and the FY2026 full-year result was 50.39%, down 4333.0% from the prior year.
- Tax Rate grew to 1.34% in Q2 2026 per ROIV's latest filing, from 4.87% in the prior quarter.
- Across five years, Tax Rate topped out at 5.34% in Q4 2024 and bottomed at 60.91% in Q2 2024.
- Historically, Tax Rate has averaged 5.75% across 5 years, with a median of 1.14% in 2022.
- The sharpest annual moves came in 2024 and 2025: Tax Rate tumbled 6037 bps in 2024, then jumped 5918 bps in 2025.
- Over 5 years, Tax Rate stood at 0.86% in 2022, then surged by 162 bps to 0.53% in 2023, then surged by 910 bps to 5.34% in 2024, then plunged by 191 bps to 4.87% in 2025, then surged by 128 bps to 1.34% in 2026.
- According to Business Quant data, Tax Rate over the past three periods registered 1.34%, 4.87%, and 4.4% for Q2 2026, Q4 2025, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | 14.20% |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | -2.36% |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | 20.98% |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | 15.11% |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | -10.89% |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | -1.96% |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | 7.49% |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | 26.36% |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | 1.34% |
| 10 | Insmed | 27.67 Bn | 26.51 Bn | 358.27 Mn | -16.71% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.34% |
| Dec 31, 2025 | -4.87% |
| Sep 30, 2025 | -4.40% |
| Jun 30, 2025 | -1.73% |
| Dec 31, 2024 | 5.34% |
| Sep 30, 2024 | -5.55% |
| Jun 30, 2024 | -60.91% |
| Dec 31, 2023 | 0.53% |
| Sep 30, 2023 | -1.34% |
| Jun 30, 2023 | -0.54% |
| Dec 31, 2022 | -0.86% |
| Sep 30, 2022 | -0.69% |
| Jun 30, 2022 | -1.14% |
| Dec 31, 2021 | -0.08% |
| Sep 30, 2021 | -0.18% |
| Jun 30, 2021 | -0.09% |
| Dec 31, 2020 | 0.08% |
| Sep 30, 2020 | -1.35% |
| Jun 30, 2020 | -18.07% |